PREVALENCE OF CARDIOVASCULAR DISEASE BY VASCULAR BED IN TYPE 2 DIABETES POPULATION IN A REAL-WORLD SETTING

被引：0
|
作者：
Weng, Wayne [1 ]
Kong, Sheldon [1 ]
Ganguly, Rahul [1 ]
Hersloev, Malene [1 ]
Brett, Jason [1 ]
Hobbs, Todd [1 ]
Baeres, Florian M. M. [1 ]
机构：
[1] Novo Nordisk Inc, Plainsboro, NJ USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2019年 / 73卷 / 09期
关键词：
D O I：
10.1016/S0735-1097(19)32365-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1178-413
引用
收藏
页码：1759 / 1759
页数：1
相关论文
共 50 条
  • [41] Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review
    Amrita Ostawal
    Emina Mocevic
    Nana Kragh
    Weiwei Xu
    Diabetes Therapy, 2016, 7 : 411 - 438
  • [42] Use of Intravascular Lithotripsy in a Population With a High Prevalence of Renal Disease and Diabetes: Insights From Real-World Data
    Mohan, Poornima
    Hartley, Adam
    Khaldi, Hani
    Sethi, Amarjit
    Petraco, Ricardo
    Al-Lamee, Rasha
    Baker, Christopher
    Khamis, Ramzi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (19) : B169 - B169
  • [43] Effect of Diabetes Treatment-Related Attributes on Costs to Type 2 Diabetes Patients in a Real-World Population
    Meng, Jie
    Casciano, Roman
    Lee, Yi-Chien
    Stern, Lee
    Gultyaev, Dmitry
    Tong, Liyue
    Kitio-Dschassi, Brice
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (04): : 428 - 434
  • [44] Risk of Complications in Type 2 Diabetes Mellitus with Increase in Disease Duration-A Report of Real-World Data of Indian Population
    Seshadri, Krishna
    Polisetti, Subhadra
    Tippisetty, Surekha
    Kolukula, Vamsi Krishna
    DIABETES, 2024, 73
  • [45] Prevalence of positive bronchodilator response in a real-world clinical setting
    Tan, Geak Poh
    Chai, Gin Tsen
    Qi, Danqing
    Abisheganaden, John Arputhan
    RESPIROLOGY, 2023, 28 : 147 - 148
  • [46] Prevalence of trastuzumab-induced cardiotoxicity in a real-world setting
    Calvillo-Arguelles, O.
    Flores-Diaz, D.
    Gonzalez-Serrano, J-P
    Lopez-Rojas, A.
    Mendoza-Galindo, L.
    Matus-Santos, J-A
    Reynoso-Noveron, N.
    Cabrera-Galeana, P.
    Bargallo-Rochaand, E.
    Arce-Salinas, C.
    CANCER RESEARCH, 2019, 79 (04)
  • [47] DRUG UTILIZATION STUDY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN AN ITALIAN REAL-WORLD SETTING: A RETROSPECTIVE STUDY
    Degli Esposti, L.
    Perrone, V
    Saragoni, S.
    Blini, V
    D'Avella, R.
    Gasperini, G.
    Lena, F.
    Fanelli, F.
    Gazzi, L.
    Giorgino, F.
    VALUE IN HEALTH, 2018, 21 : S137 - S138
  • [48] Improved glycaemic control in people with type 2 diabetes initiating or switching to IDegAsp in a real-world setting in China
    Guo, Lixin
    Chen, Liming
    Zhao, Fan
    Liu, Xiaoyun
    Ding, Hongcheng
    Wang, Kun
    Zhong, Xing
    Shankarappa, Vinay Babu
    Chaudhary, Gaurav
    DIABETES OBESITY & METABOLISM, 2025, 27 (03): : 1388 - 1396
  • [49] Switching to insulin degludec (IDeg) improves glycaemic control in patients with Type 2 diabetes in a real-world setting
    Feher, M.
    Tentolouris, N.
    Knudsen, S.
    Lapolla, A.
    Prager, R.
    Phan, T. M.
    Wolden, M. L.
    Schultes, B.
    DIABETIC MEDICINE, 2018, 35 : 203 - 203
  • [50] Metabolic Control and Adherence to Therapy in Type 2 Diabetes Mellitus Patients Using IDegLira in a Real-World Setting
    Cheli Melzer-Cohen
    Gabriel Chodick
    Shiran Naftelberg
    Naim Shehadeh
    Avraham Karasik
    Diabetes Therapy, 2020, 11 : 185 - 196
12345